Casi Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.15

+0.01 (+3.57%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +27,575.9% upside

Low Target $29.11

Average Target $40.13

High Target $50.28

Current Price $0.15

Current
$0.15

Target
$40.13

$29.11 $40.13 avg $50.28

Scenario Analysis

Bear Case

$29.11

19,975.9%

Low target

Base Case

$40.13

+27,575.9%

Avg target

Bull Case

$50.28

+34,575.9%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$3.09

-95.3% from high

52-Week Low

$0.05

+190.0% from low

Target vs 52W High

$40.13

+1,198.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+18.4%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.8%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+160.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-1.8%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.1%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-28.5%